West Pharmaceutical Services | أرباح التشغيل



Operating Profit تغيير تاريخ
Align Technology USD 144.15M 18.15M 2024-12
Avanos Medical USD -418500000 430.5M 2024-12
Baxter International USD -435000000 590M 2024-12
Becton, Dickinson and Co. USD 453M 195M 2024-12
Charles River Laboratories USD -167687000 285.09M 2024-12
Cooper Companies USD 182M 16.4M 2025-01
Dentsply International USD -509000000 47M 2024-12
Haemonetics USD 59.03M 7.33M 2024-12
ICU Medical USD 37.69M 29.46M 2024-12
Insulet USD 109.3M 21.2M 2024-12
Integra LifeSciences USD 35.23M 43.36M 2024-12
IQVIA Holdings USD 626M 76M 2024-12
J&J USD 13.63B 9.74B 2025-03
Medtronic USD 1.65B 51M 2025-01
Merit Medical Systems USD 41.03M 4.47M 2025-03
Neogen USD 5.42M 462.9M 2025-02
Quidel USD -100400000 115.4M 2024-12
Repligen USD -36501000 28.9M 2024-12
Solventum Corp 136M 139M 2024-12
STAAR Surgical USD -27910000 33.59M 2024-12
Terumo JPY 45.78B 2.7B 2024-12
West Pharmaceutical Services USD 107M 52.6M 2025-03



West Pharmaceutical Services أرباح التشغيل - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Apr 2025.